Yahoo
Paris - Delayed Quote EUR

Spineway SA (ALSPW.PA)

0.0858 -0.0012 (-1.38%)
At close: 5:35:09 PM GMT+1
Chart Range Bar
Loading chart for ALSPW.PA
  • Previous Close 0.0870
  • Open 0.0850
  • Bid --
  • Ask --
  • Day's Range 0.0816 - 0.0870
  • 52 Week Range 0.0816 - 0.2110
  • Volume 17,284
  • Avg. Volume 153,735
  • Market Cap (intraday) 3.05M
  • Beta (5Y Monthly) 0.22
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0600
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 0.21

Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.

www.spineway.com

43

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .

YTD Return

ALSPW.PA
43.55%
CAC 40 (^FCHI)
1.25%

1-Year Return

ALSPW.PA
43.18%
CAC 40 (^FCHI)
0.90%

3-Year Return

ALSPW.PA
99.84%
CAC 40 (^FCHI)
13.98%

5-Year Return

ALSPW.PA
100.00%
CAC 40 (^FCHI)
16.18%

Analyst Insights

View More

Analyst Price Targets

0.21
0.21 Average
0.0858 Current
0.21 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -18.23%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    12.96M

  • Net Income Avi to Common (ttm)

    -2.36M

  • Diluted EPS (ttm)

    -0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: